SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alessandro Stefani, Francesco Marzetti, Mariangela Pierantozzi, Simona Petrucci, Enrica Olivola, Salvatore Galati, Mario Stampanoni Bassi, Paola Imbriani, Enza Maria Valente, Francesco Saverio Pastore, Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson’s disease, Neurological Sciences, 2013, 34, 3, 383

    CrossRef

  2. 2
    Douglas E. Hobson, Asymmetry in parkinsonism, spreading pathogens and the nose, Parkinsonism & Related Disorders, 2012, 18, 1, 1

    CrossRef

  3. 3
    Krisztina K. Johansen, Kåre Hasselberg, Linda R. White, Matthew J. Farrer, Jan O. Aasly, Genealogical studies in LRRK2-associated Parkinson’s disease in central Norway, Parkinsonism & Related Disorders, 2010, 16, 8, 527

    CrossRef

  4. 4
    L. Correia Guedes, J.J. Ferreira, M.M. Rosa, M. Coelho, V. Bonifati, C. Sampaio, Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review, Parkinsonism & Related Disorders, 2010, 16, 4, 237

    CrossRef

  5. 5
    Anna De Rosa, Chiara Criscuolo, Pietro Mancini, Marina De Martino, Ilaria Anna Giordano, Sabina Pappatà, Alessandro Filla, Giuseppe De Michele, Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy, Parkinsonism & Related Disorders, 2009, 15, 3, 242

    CrossRef

  6. 6
    Elisa Greggio, Mark R Cookson, Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions, ASN NEURO, 2009, 1, 1, 13

    CrossRef

  7. 7
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  8. 8
    Avner Thaler, Elissa Ash, Ziv Gan-Or, Avi Orr-Urtreger, Nir Giladi, The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews, Journal of Neural Transmission, 2009, 116, 11, 1473

    CrossRef

  9. 9
    Christine Klein, Katja Lohmann-Hedrich, Impact of recent genetic findings in Parkinson??s disease, Current Opinion in Neurology, 2007, 20, 4, 453

    CrossRef

  10. 10
    D Civitelli, P Tarantino, G Nicoletti, IC Cirò Candiano, F Annesi, EV De Marco, S Carrideo, FE Rocca, F Condino, P Spadafora, P Pugliese, S D’Asero, M Morelli, S Paglionico, G Annesi, A Quattrone, LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson’s disease, Clinical Genetics, 2007, 71, 4
  11. 11
    Andrea Tedde, Silvia Bagnoli, Elena Cellini, Benedetta Nacmias, Silvia Piacentini, Sandro Sorbi, No Association Between the LRRK2 G2019S Mutation and Alzheimer’s disease in Italy, Cellular and Molecular Neurobiology, 2007, 27, 7, 877

    CrossRef

  12. 12
    Yue Huang, Glenda M. Halliday, Himesha Vandebona, George D. Mellick, Frank Mastaglia, Julia Stevens, John Kwok, Michael Garlepp, Peter A. Silburn, Malcolm K. Horne, Katya Kotschet, Alison Venn, Dominic B. Rowe, Justin P. Rubio, Carolyn M. Sue, Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease, Movement Disorders, 2007, 22, 7
  13. 13
    K. Kalinderi, L. Fidani, S. Bostantjopoulou, Z. Katsarou, A. Kotsis, The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease, European Journal of Neurology, 2007, 14, 10